Follicular Thyroid Carcinoma Arising from the Struma Ovarii Coexisting with Papillary Thyroid Carcinoma, Hashimoto’s Thyroiditis and Polycystic Ovarian Syndrome—a Case Report and Literature Review

References

• Wolff EF, Hughes M, Merino MJ. et al. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer. Thyroid. 2010;20(9):981–987. doi:10.1089/thy.2009.0458
   PubMed Web of Science ®Google Scholar
• Doldi N, Taccagni GL, Bassan M, et al. Hashimoto’s disease in a papillary carcinoma of the thyroid originating in a teratoma of the ovary (malignant struma ovarii). Gynecological Endocrinol. 1998;12(1):41–42. doi:10.3109/09513599809024969
   PubMed Web of Science ®Google Scholar
• Talerman A. Germ cell tumors of the ovary. In: Kurman RL. editor. Blaustein’s Pathology of the Female Genital Tract. Vol. 3, edn. New York, NY, USA: Springer-Verlag;2011:659–721
   Google Scholar
• Roth LM, Karseladze AI. Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis. Int J Gynecol Pathol. 2008;27(2):213–222. doi:10.1097/PGP.0b013e318158e958
   PubMed Web of Science ®Google Scholar
• Caturegli P, De Remigis A, Rose NR. Hashimoto’s thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4–5):391–397. doi:10.1016/j.autrev.2014.01.007
   PubMed Web of Science ®Google Scholar
• Ho JH, Abd Wahab AV, Fung YK, et al. An adolescent girl with coexisting ovarian mature cystic teratoma and HAIR-AN syndrome, an extreme subtype of polycystic ovarian syndrome. Endocrinol Diabetes Metab Case Rep. 2021;2021. Doi:10.1530/EDM-20-0195
   PubMedGoogle Scholar
• Nielsen VT. A benign cystic teratoma of the ovary with chronic thyroiditis. Am J Obstet Gynecol. 1984;148(8):1142–1144. doi:10.1016/0002-9378(84)90645-8
   PubMed Web of Science ®Google Scholar
• Erez SE, Richart RM, Shettles LB. Hashimoto’s disease in a benign cystic teratoma of the ovary. Am J Obstet Gynecol. 1965;92(2):273–274. doi:10.1016/S0002-9378(65)80023-0
   PubMed Web of Science ®Google Scholar
• Watson AA. Histological Hashimoto’s disease in a benign cystic ovarian teratoma. J Clin Pathol. 1972;25(3):240–242. doi:10.1136/jcp.25.3.240
   PubMed Web of Science ®Google Scholar
• Farrell DJ, Bloxham CA, Scott DJ. Hashimoto’s disease in a benign cystic teratoma of the ovary. Histopathology. 1991;19(3):283–284. doi:10.1111/j.1365-2559.1991.tb00038.x
   PubMed Web of Science ®Google Scholar
• Carvalho JP, Carvalho FM, Lima de Oliveira FF, et al. Hypothyroidism following struma ovarii tumor resection: a case report. Rev Hosp Clin Fac Med Sao Paulo. 2002;57(3):112–114. doi:10.1590/S0041-87812002000300006
   PubMedGoogle Scholar
• Amareen VN, Haddad FH, Al-Kaisi NS. Hypothyroidism due to Hashimoto thyroiditis post struma ovarii excision. Saudi Med J. 2004;25(7):948–950.
   PubMed Web of Science ®Google Scholar
• Morrissey K, Winkel C, Hild S, et al. Struma ovarii coincident with Hashimoto’s thyroiditis: an unusual cause of hyperthyroidism. Fertil Steril. 2007;88(2):497. [ e15-7]. doi:10.1016/j.fertnstert.2006.11.095
   Web of Science ®Google Scholar
• Bozkurt NC, Karbek B, Ozkaya EC, et al. Struma ovarii presenting with Hashimoto’s thyroiditis: a case report. J Med Case Rep. 2011;5(1):572. doi:10.1186/1752-1947-5-572
   PubMedGoogle Scholar
• Lupi I, Fessehatsion R, Manca A, et al. Hashimoto’s thyroiditis in a benign cystic teratoma of the ovary: case report and literature review. Gynecol Endocrinol. 2012;28(1):39–42. doi:10.3109/09513590.2011.579659
   PubMed Web of Science ®Google Scholar
• Berendt-Obolonczyk M, Siekierska-hellmann M, Wojtylak S, et al. From struma ovarii to Hashimoto disease—an unusual diagnosis of primary hypothyroidism: case report. Gynecol Endocrinol. 2012;28(1):43–45. doi:10.3109/09513590.2011.588750
   PubMed Web of Science ®Google Scholar
• Laganà AS, Santoro G, Triolo O, Giacobbe V, Certo R, Palmara V. Hashimoto thyroiditis onset after laparoscopic removal of struma ovarii: an overview to unravel a rare and intriguing finding. Clin Exp Obstet Gynecol. 2015;42(5):673–678. doi:10.12891/ceog1992.2015
   PubMed Web of Science ®Google Scholar
• Russo M, Marturano I, Masucci R, et al. Metastatic malignant struma ovarii with coexistence of Hashimoto’s thyroiditis. Endocrinol Diabetes Metab Case Rep. 2016;2016:160030. doi:10.1530/EDM-16-0030
   PubMedGoogle Scholar
• Koehler VF, Keller P, Waldmann E, et al. An unusual case of struma ovarii. Endocrinol Diabetes Metab Case Rep. 2021;1:2021.
   Google Scholar
• Yi Z, Chang W, Guo-Nan Z, et al. Papillary thyroid cancer located in malignant struma ovarii with omentum metastasis: a case report and review of the literature. World J Surg Onco. 2016;14(1):17. doi:10.1186/s12957-016-0776-x
   PubMedGoogle Scholar
• Al-Shammaa M, Abdlkadir A, Al-Adhami D, et al. Thyroid carcinoma arising from struma ovarii at adolescence: a challenging case with favorable outcome. Cureus. 2023;15(10):e47163. doi:10.7759/cureus.47163
   PubMed Web of Science ®Google Scholar
• Salman W, Singh M, Twaij Z. A case of papillary thyroid carcinoma in struma ovarii and review of the literature. Patholog Res Int. 2010;2010:352476. doi:10.4061/2010/352476
   PubMedGoogle Scholar
• Zhang X, Axiotis C. Thyroid-type carcinoma of struma ovarii. Arch Pathol Lab Med. 2010;134(5):786–791. doi:10.5858/134.5.786
   PubMed Web of Science ®Google Scholar
• Hatami M, Breining D, Owers RL, et al. Malignant struma ovarii-A case report and review of the literature. Gynecol Obstet Invest. 2008;65(2):104–107. doi:10.1159/000108654
   PubMed Web of Science ®Google Scholar
• Mulita F, Oikonomou N, Tchabashvili L, et al. A giant ovarian mucinous tumor in a 58-year-old postmenopausal patient with persistent abdominal pain and high serum levels of CA 19-9. Pan Afr Med J. 2020;37:76. doi:10.11604/pamj.2020.37.76.25932
   PubMed Web of Science ®Google Scholar
• Mulita F, Tavlas P, Maroulis I. A giant ovarian mass in a 68-year-old female with persistent abdominal pain and elevated serum CA-125 level. Prz Menopauzalny. 2020;19(2):108–110. doi:10.5114/pm.2020.97870
   PubMedGoogle Scholar
• Mulita F, Liolis E, Kehagias D, et al. An enormous pelvic tumor in a 46-year-old woman with an elevated serum CA 125 level, what lies beneath it? Investigation of uterine tumors in postmenopausal women. Prz Menopauzalny. 2021;20(3):154–157. doi:10.5114/pm.2021.109773
   PubMedGoogle Scholar
• Gaberscek S, Zaletel K, Schwetz V, et al. Mechanisms in endocrinology: thyroid and polycystic ovary syndrome. Eur J Endocrinol. 2015;172(1):R9–21. doi:10.1530/EJE-14-0295
   PubMed Web of Science ®Google Scholar
• Kim JJ, Yoon JW, Kim MJ, et al. Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls. Hum Fertil. 2022;25(1):128–134. doi:10.1080/14647273.2019.1709668
   PubMed Web of Science ®Google Scholar
• Hanege FM, Tuysuz O, Celik S, et al. Hashimoto’s thyroiditis in papillary thyroid carcinoma: a 22-year study. Acta Otorhinolaryngol Ital. 2021;41(2):142–145. doi:10.14639/0392-100X-N1081
   PubMed Web of Science ®Google Scholar
• Xu S, Huang H, Qian J, et al. Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes. JAMA Network Open. 2021;4(7):e2118526. doi:10.1001/jamanetworkopen.2021.18526
   PubMed Web of Science ®Google Scholar
• Fitko R, Kucharski J, Szlezyngier B. The importance of thyroid hormone in experimental ovarian cyst formation in gilts. Anim Reprod Sci. 1995;39(2):159–168. doi:10.1016/0378-4320(95)01382-A
   Web of Science ®Google Scholar
• Leong A, Roche PJ, Paliouras M, et al. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma. J Clin Endocrinol Metab. 2013;98(12):4599–4605. doi:10.1210/jc.2013-1782
   PubMed Web of Science ®Google Scholar
• Limaiem F, Bouraoui S. Follicular carcinoma arising from struma ovarii. A case report. Pathologica. 2020;112(4):224–228. doi:10.32074/1591-951X-122
   PubMed Web of Science ®Google Scholar
• McGill J, Sturgeon C, Angelos P.metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation. Endocr Pract. 2009;15(2):167–173. doi:10.4158/EP.15.2.167
   PubMed Web of Science ®Google Scholar
• Leite I, Cunha TM, Figueiredo JP, et al. Papillary carcinoma arising in struma ovarii versus ovarian metastasis from primary thyroid carcinoma: a case report and review of the literature. J Radiol Case Rep. 2013;7(10):24–33. doi:10.3941/jrcr.v7i10.1593
   PubMedGoogle Scholar
• Brusca N, Del Duca SC, Salvatori R, et al. A case report of thyroid carcinoma confined to ovary and concurrently occult in the thyroid: is conservative treatment always advised? Int J Endocrinol Metab. 2015;13(1):e18220. doi:10.5812/ijem.18220
   PubMedGoogle Scholar
• Gomes-Lima CJ, Nikiforov YE, Lee W, et al. Synchronous independent papillary thyroid carcinomas in struma ovarii and the thyroid gland with different RAS mutations. J Endocr Soc. 2018;2(8):944–948. doi:10.1210/js.2018-00132
   PubMedGoogle Scholar
• Addley S, Mihai R, Alazzam M, et al. Malignant struma ovarii: surgical, histopathological and survival outcomes for thyroid-type carcinoma of struma ovarii with recommendations for standardising multi-modal management. A retrospective case series sharing the experience of a single institution over 10 years. Arch Gynecol Obstet. 2021;303(4):863–870. doi:10.1007/s00404-021-05969-0
   PubMed Web of Science ®Google Scholar
• Mulita F, Verras GI, Dafnomili VD, et al. Thyroidectomy for the management of differentiated thyroid carcinoma and their outcome on early postoperative complications: a 6-year single-centre retrospective study. Chirurgia. 2022;117(5):556–562. doi:10.21614/chirurgia.2736
   PubMed Web of Science ®Google Scholar
• Mulita F, Theofanis G, Verras GI, et al. Comparison of postoperative bleeding using harmonic scalpel and LigaSure in thyroid surgery: a 15-year single-centre retrospective study. Med Glas. 2023;20(2):1.
   Google Scholar
• Yassa L, Sadow P, Marqusee E. Malignant struma ovarii. Nat Clin Pract Endocrinol Metab. 2008;4(469):– 472. doi:10.1038/ncpendmet0887
   PubMedGoogle Scholar
• Gonzalez Aguilera B, Guerrero Vazquez R, Gros Herguido N, et al. The lack of consensus in management of malignant struma ovarii. Gynecol Endocrinol. 2015;31(4):258–259. doi:10.3109/09513590.2014.995616
   PubMed Web of Science ®Google Scholar
• Wu M, Hu F, Huang X, et al. Extensive peritoneal implant metastases of malignant struma ovarii treated by thyroidectomy and 131I therapy: a case report. Medicine. 2018;97(51):e13867. doi:10.1097/MD.0000000000013867
   PubMed Web of Science ®Google Scholar
• Feldt-rasmussen U, Rasmussen AK. Autoimmunity in differentiated thyroid cancer: significance and related clinical problems. Hormones. 2010;9(2):109–117. doi:10.14310/horm.2002.1261
   PubMedGoogle Scholar
• Gofredo P, Swaka AM, Pura J, et al. Malignant struma ovarii: a population level analysis of a large series of 68 patients. Thyroid. 2015;25(2):211–215. doi:10.1089/thy.2014.0328
   PubMed Web of Science ®Google Scholar
• Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341–1346. doi:10.1089/thy.2017.0500
   PubMed Web of Science ®Google Scholar
• Anand B, Ramdas A, Ambroise MM, Kumar NP. The Bethesda system for reporting thyroid cytopathology: a cytohistological study. J Thyroid Res. 2020;2020:8095378. doi:10.1155/2020/8095378
   PubMed Web of Science ®Google Scholar
• Mulita F, Iliopoulos F, Tsilivigkos C, et al. Cancer rate of Bethesda category II thyroid nodules. Med Glas. 2022;19(1):1.
   Google Scholar
• Kopczynski J, Suligowska A, Niemyska K, et al. The influence of the reclassification of NIFTP as an uncertain tumour on risk of malignancy for the diagnostic categories according to the Bethesda system for reporting thyroid cytopathology. Endokrynol Pol. 2019;70(3):232–236. doi:10.5603/EP.a2019.0008
   PubMed Web of Science ®Google Scholar